FAYEZ SAROFIM & CO
Institutional investor · Portfolio as of Q4 2018
Top Holdings238 positions
Coca-Cola Co/The | 21.7M | $1B | 6.2% | $37.45 | 0.00% | 1 qtr | First report 0 |
Philip Morris International In | 14.4M | $964M | 5.8% | $45.25 | 0.00% | 1 qtr | First report 0 |
T Rowe Price Group Inc | 8M | $739.3M | 4.5% | $67.30 | 0.00% | 1 qtr | First report 0 |
Altria Group Inc | 14.9M | $734.5M | 4.4% | $27.35 | 0.00% | 1 qtr | First report 0 |
Apple Inc | 4.6M | $732M | 4.4% | $37.39 | 0.00% | 1 qtr | First report 0 |
Exxon Mobil Corp | 10.1M | $687.1M | 4.1% | $48.28 | 0.00% | 1 qtr | First report 0 |
Microsoft Corp | 6.2M | $632.9M | 3.8% | $94.43 | 0.00% | 1 qtr | First report 0 |
Chevron Corp | 5.1M | $550.3M | 3.3% | $77.82 | 0.00% | 1 qtr | First report 0 |
ENTERPRISE PRODUCTS PARTNERS | 19.7M | $485.4M | 2.9% | $13.89 | 0.00% | 1 qtr | First report 0 |
JPMorgan Chase & Co | 4.2M | $414.8M | 2.5% | $79.10 | 0.00% | 1 qtr | First report 0 |
Facebook Inc | 3.1M | $411.6M | 2.5% | $129.85 | 0.00% | 1 qtr | First report 0 |
McDonald's Corp | 2.1M | $380M | 2.3% | $148.01 | 0.00% | 1 qtr | First report 0 |
Bank of New York Mellon Corp/T | 7.4M | $348.1M | 2.1% | $38.03 | 0.00% | 1 qtr | First report 0 |
Chubb Ltd | 2.6M | $335.6M | 2.0% | $114.00 | 0.00% | 1 qtr | First report 0 |
Procter & Gamble Co/The | 3.5M | $317.3M | 1.9% | $75.31 | 0.00% | 1 qtr | First report 0 |
AbbVie Inc | 3.4M | $316.7M | 1.9% | $66.47 | 0.00% | 1 qtr | First report 0 |
PepsiCo Inc | 2.6M | $285.8M | 1.7% | $86.72 | 0.00% | 1 qtr | First report 0 |
Johnson & Johnson | 2.1M | $276.9M | 1.7% | $104.33 | 0.00% | 1 qtr | First report 0 |
Abbott Laboratories | 3.8M | $274.5M | 1.7% | $62.83 | 0.00% | 1 qtr | First report 0 |
Texas Instruments Inc | 2.9M | $269.9M | 1.6% | $76.19 | 0.00% | 1 qtr | First report 0 |
FAYEZ SAROFIM & CO manages $16.6B across 238 positions as of Q4 2018. Top holdings: KO (6.2%), PM (5.8%), TROW (4.5%). Fund DNA: Steady Compounder. HoldingsIntel Score: 4/5.0.
First quarter we have for this fund: 238 positions, nothing earlier to compare. No standout high-conviction moves this quarter. Portfolio: $16.6B across 238 positions.
Top holdings by portfolio weight
Portfolio allocation by GICS sector
Behavioral investing profile
Position Outcomes
Best and worst performing positions by estimated return
Cost basis estimates based on full filing history using quarter-end prices. Actual transaction prices are not disclosed in 13F filings.
Similar Funds
Funds with similar investing DNA
Explore More
Accumulation Streaks
Positions with 2+ consecutive quarters of increases - persistent directional conviction.
Continue exploring
Data sourced from SEC EDGAR 13F filings. Not financial advice. Full disclaimer
Verify source filings on SEC EDGAR